PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001140361-23-039544
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$11.53M | -$5.82M | -$588.93K | -$2.93M |
| EPS Diluted | -$0.37 | -$0.20 | -$0.03 | -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end
